Public SEC Form D records
Biotech Form D filings - September 2026
This page lists the 71 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers in September 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 71
- Issuers
- 69
- Combined disclosed
- $1.5B
Directory links
Filing records
71 crawlable filing links in this facet.
- GT Biopharma, Inc.September 29, 2026 / Reg D 506(b) / CA$39.0M
- Vetmab Biosciences, Inc.September 29, 2026 / Reg D 506(b) / CA$11.9M
- Conexeu Sciences Inc.September 29, 2026 / Reg D 506(b) / NV$30.9K
- HAWKHILL THERAPEUTICS LtdSeptember 29, 2026 / Reg D 506(b)$290.5K
- Sialia Therapeutics, Inc.September 29, 2026 / Reg D 506(b) / CA$1.5M
- Evia Bio, Inc.September 28, 2026 / Reg D 506(b) / MN$5.5M
- Vertical Longevity Pharmaceuticals, Inc.September 28, 2026 / Reg D 506(b) / CA$110.0K
- Pictura Bio US, Inc.September 28, 2026 / Reg D 506(b)$15.0M
- Pictura Bio US, Inc.September 28, 2026 / Reg D 506(b)$17.5M
- Pace Pharmaceuticals, Inc.September 28, 2026 / Reg D 506(c) / CAUndisclosed
- Laurentide Therapeutics Inc.September 28, 2026 / Reg D 506(b) / GA$100.0K
- Xact Bio, Inc.September 28, 2026 / Reg D 506(b) / MA$18.0M
- Dignify Therapeutics, LLCSeptember 25, 2026 / Reg D 506(b) / NC$3.0M
- Verinomics, Inc.September 25, 2026 / Reg D 506(b) / CT$12.8M
- Navigator Medicines, Inc.September 25, 2026 / Reg D 506(b) / CA$40.0M
- EyeMacular Regeneration, Inc.September 25, 2026 / Reg D 506(b) / MN$6.0M
- Way Biosolutions, Inc.September 25, 2026 / Reg D 506(b) / MA$2.0M
- Aponia Laboratories IncSeptember 24, 2026 / Reg D 506(b) / NHUndisclosed
- Argonaute RNA LtdSeptember 24, 2026 / Reg D 506(b)$1.8M
- Biophytis SASeptember 23, 2026 / Reg D 506(b)$2.6M
- Caspian Therapeutics, Inc.September 23, 2026 / Reg D 506(b) / CA$50.0M
- Hera Biotech, Inc.September 23, 2026 / Reg D 506(b) / TX$5.0M
- Uvantis Therapeutics, Inc.September 23, 2026 / Reg D 506(b) / MD$5.0M
- Navion Neurosciences Inc.September 22, 2026 / Reg D 506(b) / VA$5.1M
- Pierrepont Therapeutics, Inc.September 22, 2026 / Reg D 506(b) / NY$5.9M
- Bioinsights, Inc.September 22, 2026 / Reg D 506(b) / FL$7.9M
- Jupiter Biomedical Research, Inc.September 21, 2026 / Reg D 506(b) / FL$1.0M
- BioStem Technologies, Inc.September 21, 2026 / Reg D 506(b) / FL$40.0M
- Lexaria Bioscience Corp.September 21, 2026 / Reg D 506(b)$113.5K
- Avery Therapeutics, Inc.September 21, 2026 / Reg D 506(b) / AZ$15.4M
- iQure Pharma Inc.September 21, 2026 / Reg D 506(b) / NJ$4.0M
- Monocacy Therapeutics Inc.September 21, 2026 / Reg D 506(b) / MD$49
- Typewriter Therapeutics, Inc.September 21, 2026 / Reg D 506(b) / MA$56.3M
- CERENOME, INC.September 18, 2026 / Reg D 506(b) / TX$20.0M
- Aqur Biosciences, Inc.September 18, 2026 / Reg D 506(b) / CA$1.5M
- FibroBiologics, Inc.September 16, 2026 / Reg D 506(b) / TX$500.0K
- Oncobiomix Inc.September 16, 2026 / Reg D 506(b) / TX$2.5M
- Hexamer Therapeutics, IncSeptember 15, 2026 / Reg D 506(b) / WA$2.5M
- Conexeu Sciences Inc.September 15, 2026 / Reg D 506(b) / NV$252.1K
- Harvard Apparatus Regenerative Technology, Inc.September 14, 2026 / Reg D 506(b) / MA$3.0M
- Moonwalk Biosciences, Inc.September 14, 2026 / Reg D 506(b) / CA$70.2M
- Tempo Therapeutics, Inc.September 11, 2026 / Reg D 506(b) / CA$14.5M
- Savannah Therapeutics, IncSeptember 11, 2026 / Reg D 506(b) / MD$6.0M
- Amplica Bio, Inc.September 11, 2026 / Reg D 506(b) / DEUndisclosed
- Quoin Pharmaceuticals Ltd.September 10, 2026 / Reg D 506(b) / VA$50.0M
- Polyrizon Ltd.September 10, 2026 / Reg D 506(b)$4.0M
- Can-Fite BioPharma Ltd.September 10, 2026 / Reg D 506(b)$8.3M
- ALZHEON, INC.September 10, 2026 / Reg D 506(b) / MA$500.0M
- seqWell Inc.September 10, 2026 / Reg D 506(b) / MA$1.0M
- Praeventix, Inc.September 10, 2026 / Reg D 506(b) / PA$5.6M
- Airway Therapeutics, Inc.September 9, 2026 / Reg D 506(b) / GA$50.6M
- BioLineRx Ltd.September 9, 2026 / Reg D 506(b)$3.8M
- Animal Biosciences, Inc.September 9, 2026 / Reg D 506(b) / MA$2.6M
- Iambic Therapeutics, Inc.September 9, 2026 / Reg D 506(b) / CA$66.5M
- Cloverleaf Bio, Inc.September 9, 2026 / Reg D 506(b) / CT$29.6M
- SAFETYSPECT INCSeptember 8, 2026 / Reg D 506(c) / ND$10.0M
- Klothea Bio, Inc.September 8, 2026 / Reg D 506(b) / FL$10.4M
- Andira Medicine Inc.September 4, 2026 / Reg D 506(b)$1.6M
- Pluri Inc.September 4, 2026 / Reg D 506(b)$3.7M
- Immunophotonics, Inc.September 4, 2026 / Reg D 506(b) / MOUndisclosed
- JUPITER NEUROSCIENCES, INC.September 4, 2026 / Reg D 506(b) / FL$774.8K
- Gossamer Bio, Inc.September 4, 2026 / Reg D 506(b) / CA$150.0M
- Dravite Therapeutics, Inc.September 3, 2026 / Reg D 506(b) / CA$53.0M
- Superluminal Medicines, Inc.September 3, 2026 / Reg D 506(b) / MA$65.5M
- Sensible Biotechnologies, Inc.September 2, 2026 / Reg D 506(b)$15.0M
- Agen Genomics, Inc.September 2, 2026 / Reg D 506(b) / CA$1.5M
- Telemachus Therapeutics, Inc.September 2, 2026 / Reg D 506(b) / PA$1.5M
- Aclarity Genomics, Inc.September 2, 2026 / Reg D 506(b) / NC$4.6M
- CYBIN INC.September 1, 2026 / Reg D 506(b)$262.0K
- Kaida BioPharma Inc.September 1, 2026 / Reg D 506(b) / FL$4.1M
- Voxcell BioInnovation Inc.September 1, 2026 / Reg D 506(b)$2.2M